close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

Strona główna・Stock List・Palvella Therapeutics Inc
Search

Palvella Therapeutics Inc

Open

SectorHealthcare

111.17 0.85

Strong Buy

Price update 20 mar 2026, 13:33 UTC

BuySell

Overview

Share price change

24h

Current

Min

110.32

Max

115.47

Key metrics

By Trading Economics

Income

-1.9M

-11M

Employees

14

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+90.56% upside

Dividends

By Dow Jones

Next Earnings

30 mar 2026

Market Stats

By TradingEconomics

Market Cap

1.6B

Previous open

110.32

Previous close

111.17

News Sentiment

By Acuity

19%

81%

20 / 350 Ranking in Healthcare

Palvella Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 mar 2026, 18:34 UTC

Earnings

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

DJ

Read

19 mar 2026, 17:43 UTC

Major Market Movers

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

DJ

Read

19 mar 2026, 23:39 UTC

Earnings

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

DJ

Read

19 mar 2026, 23:39 UTC

Earnings

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

DJ

Read

19 mar 2026, 23:39 UTC

Earnings

Li Ning: Outdoor Category Continued Growing >2331.HK

DJ

Read

19 mar 2026, 23:38 UTC

Earnings

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

DJ

Read

19 mar 2026, 23:33 UTC

Market Talk

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

McCormick Has a Market Value of Around $14.8B -- WSJ

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

DJ

Read

19 mar 2026, 22:23 UTC

Market Talk

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

DJ

Read

19 mar 2026, 22:09 UTC

Market Talk
Major News Events

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

DJ

Read

19 mar 2026, 22:06 UTC

Market Talk

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

DJ

Read

19 mar 2026, 22:04 UTC

Earnings
Acquisitions, Mergers, Takeovers

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

DJ

Read

19 mar 2026, 22:03 UTC

Market Talk
Major News Events

Global Energy Roundup: Market Talk

DJ

Read

19 mar 2026, 22:03 UTC

Market Talk
Major News Events

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

DJ

Read

19 mar 2026, 21:51 UTC

Earnings
Acquisitions, Mergers, Takeovers

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

DJ

Read

19 mar 2026, 20:57 UTC

Major News Events

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

DJ

Read

19 mar 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

DJ

Read

19 mar 2026, 20:19 UTC

Major News Events

Brent Crude Retreats After Touching $119 -- WSJ

DJ

Read

19 mar 2026, 19:49 UTC

Market Talk

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

DJ

Read

19 mar 2026, 19:26 UTC

Major News Events

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

DJ

Read

19 mar 2026, 19:10 UTC

Market Talk
Major News Events

Natural Gas Rises in Volatile Trading -- Market Talk

DJ

Read

19 mar 2026, 19:06 UTC

Major News Events

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

DJ

Read

19 mar 2026, 18:08 UTC

Market Talk
Major News Events

Silver Extends Slide to Seven Straight Sessions -- Market Talk

DJ

Read

Peer Comparison

Price change

Palvella Therapeutics Inc Forecast

Price Target

By TipRanks

90.56% upside

12 Months Forecast

Average 217.68 USD  90.56%

High 267 USD

Low 76.43 USD

Based on 12 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

12

Buy

0

Hold

0

Sell

Based on 12 analysts giving stock ratings to Palvella Therapeutics Inc - Dist in the past 3 months.

Sentiment

By Acuity

20 / 350 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

917.46

↑ +0.11%

JNJ

Johnson and Johnson

237.66

↑ +0.19%

ABBV

AbbVie Inc

206.13

↓-1.03%

NVS

Novartis AG

148.1

↓-1.11%

AZN

AstraZeneca PLC

188.8

↑ +0.2%
help-icon Live chat